| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f6be7b5f316f050e9151b3afd8936f7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2887
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2833 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2003-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12489fa9a3b85c2a5233004f7fac0de9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b74e8f344ab2bb9a2eaa431c1d57748
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a63c5d8ba58c8c48ef7d1e511d0c715f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c481b7bfb96f9e2172bfd49213cc777b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69c3bc4a43030ae1232de13fe8a3ed22 |
| publicationDate |
2004-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2498315-A1 |
| titleOfInvention |
Cytokine production-inducing antibody |
| abstract |
The present invention relates to a method for measuring the activation of an effector cell belonging to the immune system, transformed or otherwise, by a monoclonal antibody (AcMo) or a polyclonal antibody, characterized in that it comprises nd a contacting of cells expressing the CD16 receptor in a reaction medium in the presence of the antibody and the antigen of said antibody and measuring the amount of at least one cytokine produced by the cell expressing the CD16 receptor. The invention also relates to the selection of antibodies having the characteristic of inducing the expression of cytokines and interleukins, especially IFN.gamma. or IL2 for the treatment of autoimmune and inflammatory diseases, cancers and infections with pathogens. |
| priorityDate |
2002-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |